
BlackRock Health Sciences Term Trust
BMEZ
Updated: 24/09/2026, 12:13:10
BlackRock Health Sciences Term Trust is a closed-end management investment company, which investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The company was founded on August 14, 2019 and is headquartered in Wilmington, DE.
No summaries found.
- Share price
- $16.70
- Market cap
- $1.69B
- Exchange
- NYSE
- Currency
- USD
- CEO
- John Perlowski
- Employees
- N/A
- IPO date
- 29/01/2020
- Beta
- 0.854
- Last dividend
- $0.00
- Day range
- $16.64 – $16.85
- 52-week range
- $13.70 – $17.25
- 1-day performance
- -1.01%
- 1-year performance
- 21.90%
- Current drawdown (1Y)
- -3.19%
- CIK
- 0001785971
- CUSIP
- 09260E105
- ISIN
- US09260E1055
- Created
- 07/12/2025, 03:03:03
- Last update
- 24/09/2026, 12:13:10
Track BlackRock Health Sciences Term Trust with an AI analyst
See which prediction-market events move BMEZ, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
BMEZ: Removal Of Options Should Improve Performance (Rating Upgrade)
Seeking Alpha • STOCK • 28/05/2026, 07:40:03
BMEZ: Sell, Distributions Down 34% And Undercovered
Seeking Alpha • STOCK • 22/03/2026, 10:15:00
Forget Software Stocks: This 8.8% Dividend Is The Real AI Bargain
Forbes • STOCK • 04/03/2026, 10:46:58